An official website of the United States government

WHO Executive Board – Pillar I Group 5 Combined Intervention
January 28, 2022


Pillar I Group 5 Combined Intervention
Agenda items 11- Immunization Agenda 2030; 12- Infection Prevention and Control; and 13- Global roadmap on defeating meningitis by 2030

World Health Organization (WHO)
150th Session of the Executive Board

Geneva, Switzerland – Virtual Meeting
January 24-29, 2022

As Delivered

Item 11: Immunization Agenda

Safe and effective vaccines remain one of the most essential public health tools to reduce morbidity and mortality throughout the life course. The COVID-19 pandemic has caused a significant disruption to immunization programs globally and we are especially concerned about the rise in zero-dose children.

We must strengthen collaboration to ensure that current vaccination programs are maintained, and to renew progress towards the Immunization Agenda 2030 impact goals.

We call on WHO, Member States, and the global community to continue important efforts to promote confidence and trust in safe and effective vaccines, including COVID-19 vaccines, and routine immunizations broadly.

Item 12: Infection Prevention and Control

The pandemic has also demonstrated that a robust and resilient healthcare system must include functional infection prevention and control programs at the national, sub-national, and facility levels to ensure patient and provider safety and combat emerging infections. Such measures are also integral to biosafety and the prevention and control of antimicrobial resistance.

We must continue to work together to minimize and prevent predictable and avoidable harm, including through community engagement with focus on marginalized and at-risk populations.

We urge WHO and all Member States to begin planning for effectively transitioning COVID-19 response investment in infection prevention and control into long-term sustainable capacity gains.

Item 13: Global Roadmap on Defeating Meningitis by 2030

We are committed to working with partners to strengthen meningitis prevention and control through improved surveillance; access to safe, effective, affordable, high-quality vaccines; timely diagnosis; and optimal clinical and therapeutic management.